HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 269 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $497,807 | +15.8% | 13,035 | +33.3% | 0.08% | +78.6% |
Q2 2022 | $430,000 | -3.8% | 9,782 | -6.6% | 0.04% | +35.5% |
Q4 2020 | $447,000 | -66.1% | 10,471 | -78.7% | 0.03% | -73.0% |
Q2 2020 | $1,319,000 | +129.8% | 49,216 | +52.1% | 0.12% | +45.6% |
Q4 2019 | $574,000 | – | 32,348 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |